Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Apr 2008 for ENCYSIVE PHARMACEUTICALS INC, €14k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
John H. Dillon II: trading record in brief
This profile gathers the share dealings of John H. Dillon II in Encysive Pharmaceuticals Inc. In total, 6 filings cover trades dated from 31 December 2005 to 1 April 2008.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 3 April 2008 came the latest disclosure, a transaction for €14k in Encysive Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John H. Dillon II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
9,121 shares@ US$2.35Common StockSEC:0001209191-08-022577:0
1,781 shares0Common StockSEC:0001209191-07-003090:0
1,744 shares0Common StockSEC:0001209191-06-053260:0
1,106 shares0Common StockSEC:0001209191-06-040885:0
1,503 shares0Common StockSEC:0001209191-06-021976:0
950 shares0Common StockSEC:0001209191-06-000839:0
6 of 6 declarations
